首页> 美国卫生研究院文献>Cancer Medicine >Metformin revert insulin‐induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells
【2h】

Metformin revert insulin‐induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells

机译:二甲双胍通过激活人结肠癌HCT116细胞的线粒体凋亡途径来逆转胰岛素诱导的奥沙利铂耐药

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Several studies have suggested that drug resistance in colon cancer patients with diabetes may be associated with long‐term insulin administration, which in turn decreases the survival rate. Metformin is a commonly used drug to treat diabetes but has been recently demonstrated to have a potential therapeutic effect on colon cancer. This study aimed to elucidate the underlying mechanism by which metformin reverts insulin‐induced oxaliplatin resistance in human colon cancer HCT116 cells.
机译:多项研究表明,结肠癌糖尿病患者的耐药性可能与长期服用胰岛素有关,从而降低了生存率。二甲双胍是治疗糖尿病的常用药物,但最近已证明对结肠癌具有潜在的治疗作用。这项研究旨在阐明二甲双胍可逆转人结肠癌HCT116细胞中胰岛素诱导的奥沙利铂耐药的潜在机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号